Lantern Pharma Inc. Increase (Decrease) in Prepaid Expenses, Other
Lantern Pharma Inc. (LTRN) reported Increase (Decrease) in Prepaid Expenses, Other of $1.03 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-03-20
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-12-31 was -$726.03K, a 247.92% decline year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-09-30 was $197.76K, a 38.92% decline year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-06-30 was $1.12M, a 1579.53% increase year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-03-31 was $440.17K, a 327.01% increase year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $1.03M, a 5.01% increase from fiscal 2021.
- Lantern Pharma Inc. increase (decrease) in prepaid expenses, other for fiscal 2021 was $984.46K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$726.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$528.27K derived: sum of 2 quarters · filed 2023-03-20 | $593.65K derived: sum of 3 quarters · filed 2023-03-20 | $1.03M 10-K · filed 2023-03-20 |
| 2022-09-30 | $197.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.32M derived: sum of 2 quarters · filed 2022-11-07 | $1.76M 10-Q · filed 2022-11-07 | $2.25M derived: sum of 4 quarters · filed 2023-03-20 |
| 2022-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.56M 10-Q · filed 2022-08-08 | $2.05M derived: sum of 3 quarters · filed 2023-03-20 | $2.38M derived: sum of 4 quarters · filed 2023-03-20 |
| 2022-03-31 | $440.17K 10-Q · filed 2022-05-03 | $930.98K derived: sum of 2 quarters · filed 2023-03-20 | $1.25M derived: sum of 3 quarters · filed 2023-03-20 | $1.32M derived: sum of 4 quarters · filed 2023-03-20 |
| 2021-12-31 | $490.82K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $814.58K derived: sum of 2 quarters · filed 2023-03-20 | $881.38K derived: sum of 3 quarters · filed 2023-03-20 | $984.46K 10-K · filed 2023-03-20 |
| 2021-09-30 | $323.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $390.57K derived: sum of 2 quarters · filed 2022-11-07 | $493.65K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $66.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $169.88K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $103.08K 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |